2023 annual financial data
Rein Therapeutics 2023 Operating margin
Rein Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -16,276 USD and net income was -15,732 USD.
Operating cash flow was -19,808,000 USD.
Get free Rein Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,276 USD
- Net income
- -15,732 USD
- Operating cash flow
- -19,808,000 USD